{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:59:00Z","timestamp":1780898340186,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04674-9","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:20:59Z","timestamp":1780896059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RET p.Cys634-driven progression of hereditary vs. sporadic medullary thyroid cancer"],"prefix":"10.1007","volume":"91","author":[{"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"7","key":"4674_CR1","doi-asserted-by":"publisher","first-page":"e240038","DOI":"10.1530\/ERC-24-0038","volume":"31","author":"A Machens","year":"2024","unstructured":"A. Machens, K. Lorenz, F. Weber, T. Brandenburg, D. F\u00fchrer-Sakel, H. Dralle, Genotype-specific development of MEN 2 constituent components in 683 RET carriers. Endocr. Relat. Cancer. 31(7), e240038 (2024). https:\/\/doi.org\/10.1530\/ERC-24-0038","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"4674_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.bjc.6605056","volume":"100","author":"MM Moura","year":"2009","unstructured":"M.M. Moura, B.M. Cavaco, A.E. Pinto, R. Domingues, J.R. Santos, M.O. Cid, M.J. Bugalho, V. Leite, Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas. Br. J. Cancer. 100(11), 1777\u20131783 (2009). https:\/\/doi.org\/10.1038\/sj.bjc.6605056","journal-title":"Br. J. Cancer"},{"issue":"2","key":"4674_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/thy.2023.0279","volume":"34","author":"B Xu","year":"2024","unstructured":"B. Xu, K. Viswanathan, M.S. Ahadi, S. Ahmadi, B. Alzumaili, M.A. Bani, E. Baudin, D.B. Behrman, M. Capelletti, N.G. Chau, F. Chiarucci, A. Chou, R. Clifton-Bligh, S. Coluccelli, D. de Biase, A. De Leo, S. Dogan, J.A. Fagin, T.L. Fuchs, A.R. Glover, J. Hadoux, L. Lacroix, L. Lamartina, D.J. Lubin, C. Luxford, K. Magliocca, T. Maloberti, A.S. Mohanty, F. Najdawi, A. Nigam, A.J. Papachristos, A. Repaci, B. Robinson, J.Y. Scoazec, Q. Shi, S. Sidhu, E. Solaroli, M. Sywak, R.M. Tuttle, B. Untch, J.A. Barletta, A. Al Ghuzlan, A.J. Gill, R. Ghossein, G. Tallini, I. Ganly, Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study. Thyroid. 34(2), 167\u2013176 (2024). https:\/\/doi.org\/10.1089\/thy.2023.0279","journal-title":"Thyroid"},{"issue":"6","key":"4674_CR4","doi-asserted-by":"publisher","first-page":"bvae048","DOI":"10.1210\/jendso\/bvae048","volume":"8","author":"AS Shirali","year":"2024","unstructured":"A.S. Shirali, M.I. Hu, Y.J. Chiang, P.H. Graham, S.B. Fisher, J.A. Sosa, N. Perrier, S. Brown, V.R. Holla, R. Dadu, N. Busaidy, S.I. Sherman, M. Cabanillas, S.G. Waguespack, M.E. Zafereo, E.G. Grubbs, Next-generation sequencing in sporadic medullary thyroid cancer patients: mutation profile and disease aggressiveness. J. Endocr. Soc. 8(6), bvae048 (2024). https:\/\/doi.org\/10.1210\/jendso\/bvae048","journal-title":"J. Endocr. Soc."},{"issue":"20","key":"4674_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","volume":"389","author":"J Hadoux","year":"2023","unstructured":"J. Hadoux, R. Elisei, M.S. Brose, A.O. Hoff, B.G. Robinson, M. Gao, B. Jarzab, P. Isaev, K. Kopeckova, J. Wadsley, D. F\u00fchrer, B. Keam, S. Bardet, E.J. Sherman, M. Tahara, M.I. Hu, R. Singh, Y. Lin, V. Soldatenkova, J. Wright, B. Lin, P. Maeda, J. Capdevila, L.J. Wirth, LIBRETTO-531 trial investigators, Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer. N Engl. J. Med. 389(20), 1851\u20131861 (2023). https:\/\/doi.org\/10.1056\/NEJMoa2309719","journal-title":"N Engl. J. Med."},{"issue":"1","key":"4674_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/thy.2024.0495","volume":"35","author":"S Hamidi","year":"2025","unstructured":"S. Hamidi, S. Yedururi, M.I. Hu, N.L. Busaidy, S.I. Sherman, C. Jimenez, E.G. Grubbs, A. Maniakas, M.E. Zafereo, V. Subbiah, S.G. Waguespack, Efficacy and safety of selective RET inhibitors in patients with advanced hereditary medullary thyroid carcinoma. Thyroid. 35(1), 6\u201317 (2025). https:\/\/doi.org\/10.1089\/thy.2024.0495","journal-title":"Thyroid"},{"issue":"3","key":"4674_CR7","doi-asserted-by":"publisher","first-page":"109549","DOI":"10.1016\/j.ejso.2024.109549","volume":"51","author":"A Machens","year":"2025","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancer. Eur. J. Surg. Oncol. 51(3), 109549 (2025). https:\/\/doi.org\/10.1016\/j.ejso.2024.109549","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"4674_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G.Waguespack; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma, Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25(6), 567\u2013610 (2015). https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"issue":"7","key":"4674_CR9","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/jc.2015-1689","volume":"100","author":"A Machens","year":"2015","unstructured":"A. Machens, H. Dralle, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100(7), 2539\u20132545 (2015). https:\/\/doi.org\/10.1210\/jc.2015-1689","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4674_CR10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s12020-025-04344-2","volume":"90","author":"A Machens","year":"2025","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Geospatial inheritance across the breadth of the RET mutational landscape of multiple endocrine neoplasia 2A. Endocrine. 90(2), 1027\u20131034 (2025). https:\/\/doi.org\/10.1007\/s12020-025-04344-2","journal-title":"Endocrine"},{"issue":"11","key":"4674_CR11","doi-asserted-by":"publisher","first-page":"e3559","DOI":"10.1210\/clinem\/dgaf171","volume":"110","author":"R Casalini","year":"2025","unstructured":"R. Casalini, C. Romei, V. Bottici, V. Cappagli, V. Tascini, A. Matrone, A. Prete, R. Ciampi, T. Ramone, R. Elisei, Prevalence and genetics of de novo MEN2 syndromes. J. Clin. Endocrinol. Metab. 110(11), e3559\u2013e3565 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgaf171","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4674_CR12","unstructured":"WHO Classification of Tumours Editorial Board, (eds.). Endocrine and neuroendocrine tumours: WHO Classification of tumours, IARC, 5th edition, Lyon 2025"},{"issue":"6973","key":"4674_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","volume":"310","author":"JM Bland","year":"1995","unstructured":"J.M. Bland, D.G. Altman, Multiple significance tests: the Bonferroni method. BMJ. 310(6973), 170 (1995). https:\/\/doi.org\/10.1136\/bmj.310.6973.170","journal-title":"BMJ"},{"key":"4674_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Y. Benjamini, Y. Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R Stat. Soc. Ser. B Stat. Method. 57, 289\u2013300 (1995). https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J. R Stat. Soc. Ser. B Stat. Method"},{"issue":"1","key":"4674_CR15","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/EJE-21-0753","volume":"186","author":"RMB Maciel","year":"2022","unstructured":"R.M.B. Maciel, A.L. Maia, Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review. Eur. J. Endocrinol. 186(1), R15\u2013R30 (2022). https:\/\/doi.org\/10.1530\/EJE-21-0753","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"4674_CR16","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2017-00317","volume":"102","author":"RK Voss","year":"2017","unstructured":"R.K. Voss, L. Feng, J.E. Lee, N.D. Perrier, P.H. Graham, S.M. Hyde, F. Nieves-Munoz, M.E. Cabanillas, S.G. Waguespack, G.J. Cote, R.F. Gagel, E.G. Grubbs, Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness. J. Clin. Endocrinol. Metab. 102(8), 2807\u20132813 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00317","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4674_CR17","doi-asserted-by":"publisher","first-page":"e3582","DOI":"10.1210\/clinem\/dgab326","volume":"106","author":"F Raue","year":"2021","unstructured":"F. Raue, T. Bruckner, K. Frank-Raue, Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 106(9), e3582\u2013e3591 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab326","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4674_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12020-026-04567-x","volume":"91","author":"A Machens","year":"2026","unstructured":"A. Machens, H. Dralle, K. Lorenz, RET germline mutations drive tumorigenesis but not tumor aggressiveness in MEN 2. Endocrine. 91(1), 75 (2026). https:\/\/doi.org\/10.1007\/s12020-026-04567-x","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04674-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:21:02Z","timestamp":1780896062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04674-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4674"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04674-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from each patient and\/or legal guardian as applicable before each RET gene test and each operation, all of which represented standard of care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"208"}}